Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationStem Cell TransplantationCombined Modality TherapyGranulocyte Colony-Stimulating FactorAntigens, CD34MelphalanHematologic NeoplasmsLeukapheresisMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseBlood Component RemovalBone Marrow TransplantationGraft SurvivalTreatment OutcomeMyeloablative AgonistsBusulfanEtoposideStem CellsHematopoietic Stem CellsLymphoma, Non-HodgkinRemission InductionRecurrenceThiotepaAntineoplastic Agents, AlkylatingCarmustineCord Blood Stem Cell TransplantationTransplantation ChimeraSalvage TherapyCytophagocytosisTissue DonorsIfosfamideVincristineDisease-Free SurvivalAmyloidosisHematopoiesisCytarabineRetrospective StudiesHodgkin DiseaseWhole-Body IrradiationSurvival RateTime FactorsNeoplasmsSurvival AnalysisHistocompatibilityHistocompatibility TestingImmunosuppressive AgentsInfectionLiver TransplantationLymphoma, T-CellVidarabineDoxorubicinLeukemia, Myeloid, AcuteTransplantation, IsogeneicLeukemiaPlatelet CountPOEMS SyndromeGraft vs Leukemia EffectFollow-Up StudiesPrednisoneMesenchymal Stem Cell TransplantationCarboplatinDexamethasoneCytomegalovirus InfectionsBlood Cell CountAntineoplastic AgentsBone Marrow PurgingProspective StudiesRecombinant ProteinsLymphomaFatal OutcomeBlood CellsCell TransplantationMyelodysplastic SyndromesKidney TransplantationFeasibility StudiesEmbryonic Stem CellsAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHematologic DiseasesHLA AntigensImmunophenotypingT-LymphocytesAdult Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionPrognosisTransplantation ImmunologyCyclosporineBone MarrowOpportunistic InfectionsBlood Transfusion, AutologousFlow Cytometry